{
    "name": "ferumoxytol",
    "comment": "Rx",
    "other_names": [
        "Feraheme"
    ],
    "classes": [
        "Iron Products"
    ],
    "source": "https://reference.medscape.com/drug/feraheme-ferumoxytol-999457",
    "pregnancy": {
        "common": [
            "Limited available data with ferumoxytol use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes",
            "In animal studies, ferumoxytol to pregnant rabbits during organogenesis caused adverse developmental outcomes including fetal malformations and decreased fetal weights at maternally toxic doses of 6 times the estimated human daily dose",
            "Untreated iron deficiency anemia (IDA) in pregnancy is associated with adverse maternal outcomes such as postpartum anemia as well as risks to the fetus associated with maternal severe hypersensitivity reactions",
            "Severe adverse reactions including circulatory failure (severe hypotension, shock including in the context of anaphylactic reaction) may occur in pregnant women with parenteral iron products, which may cause fetal bradycardia, especially during second and third trimester"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "There are no data on the presence of ferumoxytol in human milk, the effects on the breastfed child, or the effects on milk production",
            "Ferumoxytol has been detected in the milk of lactating rats",
            "Developmental and health benefits of breastfeeding should be considered along with the motherâ€™s clinical need for ferumoxytol and any potential adverse effects on the breastfed child from ferumoxytol or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": [
                {
                    "type": "Serious hypersensitivity/ anaphylaxis reactions",
                    "description": [
                        "Fatal and serious hypersensitivity reactions including anaphylaxis have occurred",
                        "Initial symptoms may include hypotension, syncope, unresponsiveness, and cardiac/cardiorespiratory arrest",
                        "Only administer as IV infusion over at least 15 minutes when personnel and therapies are immediately available for the treatment of anaphylaxis and other hypersensitivity reactions",
                        "Observe for signs or symptoms of hypersensitivity reactions during and for at least 30 minutes following infusion, including monitoring of blood pressure and pulse during and after administration",
                        "Hypersensitivity reactions have occurred in patients in whom a previous dose was tolerated"
                    ]
                }
            ]
        },
        "contraindicators": {
            "common": [
                "Known hypersensitivity to ferumoxytol or any of its components",
                "History of allergic reaction to any intravenous iron product"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "May cause life-threatening hypersensitivity reactions such as anaphylaxis and/or anaphylactoid reactions (see Black Box Warnings)",
                "Elderly patients (>65 years) or patients with multiple comorbidities who experience a serious hypersensitivity reaction due to ferumoxytol may have more severe outcomes",
                "Risk of anaphylaxis increases in patients with multiple drug allergies",
                "Anaphylactic reactions presenting with cardiac/cardiorespiratory arrest, syncope, hypotension and unresponsiveness have been identified in post-marketing reports",
                "Clinically significant hypotension may occur; in a clinical study with ferumoxytol in patients with IDA, regardless of etiology, moderate hypotension was reported in 0.2% (2/997) of subjects",
                "Excessive therapy with IV iron can lead to excess storage of iron with the possibility of iatrogenic hemosiderosis; monitor the hematologic response during IV iron therapy; do not administer ferumoxytol to patients with iron overload; within 24 hr following administration, laboratory assays may overestimate serum iron and transferrin bound iron by also measuring iron in the ferumoxytol",
                "Monitor hematologic responses during therapy, do not administer if evidence of iron overload",
                "Can alter magnetic resonance imaging (MRI) studies"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Headache",
            "percent": "1.8-3.4"
        },
        {
            "name": "Nausea",
            "percent": "1.8-3.1"
        },
        {
            "name": "Dizziness",
            "percent": "1.5-2.6"
        },
        {
            "name": "Hypotension",
            "percent": "2.5"
        },
        {
            "name": "Peripheral edema",
            "percent": "2"
        },
        {
            "name": "Edema",
            "percent": "1.5"
        },
        {
            "name": "Vomiting",
            "percent": "1.5"
        },
        {
            "name": "Fatigue",
            "percent": "1.5"
        },
        {
            "name": "Abdominal pain",
            "percent": "1.3"
        },
        {
            "name": "Chest pain",
            "percent": "1.3"
        },
        {
            "name": "Cough",
            "percent": "1.3"
        },
        {
            "name": "Pruritus",
            "percent": "1.2"
        },
        {
            "name": "Pyrexia",
            "percent": "1"
        },
        {
            "name": "Diarrhea",
            "percent": "1"
        },
        {
            "name": "Back pain",
            "percent": "1"
        },
        {
            "name": "Muscle spasms",
            "percent": "1"
        },
        {
            "name": "Dyspnea",
            "percent": "1"
        },
        {
            "name": "Rash",
            "percent": "1"
        },
        {
            "name": "Hypotension",
            "percent": "0.4"
        },
        {
            "name": "Chest pain",
            "percent": "0.2-0.3"
        },
        {
            "name": "Arthralgia",
            "percent": "0.3"
        },
        {
            "name": "Dyspnea",
            "percent": "0.3"
        },
        {
            "name": "Flushing",
            "percent": "0.2"
        },
        {
            "name": "Chest discomfort",
            "percent": "0.2"
        },
        {
            "name": "Nausea",
            "percent": "0.2"
        },
        {
            "name": "Back pain",
            "percent": "0.2"
        },
        {
            "name": "Dizziness",
            "percent": "0.2"
        },
        {
            "name": "Headache",
            "percent": "0.2"
        },
        {
            "name": "Life",
            "percent": null
        },
        {
            "name": "threatening anaphylactic",
            "percent": null
        },
        {
            "name": "anaphylactoid reactions",
            "percent": null
        },
        {
            "name": "Cardiac",
            "percent": null
        },
        {
            "name": "cardiorespiratory arrest",
            "percent": null
        },
        {
            "name": "Clinically significant hypotension",
            "percent": null
        },
        {
            "name": "Loss of consciousness",
            "percent": null
        },
        {
            "name": "Unresponsiveness",
            "percent": null
        },
        {
            "name": "Tachycardia",
            "percent": null
        },
        {
            "name": "rhythm abnormalities",
            "percent": null
        },
        {
            "name": "Angioedema",
            "percent": null
        },
        {
            "name": "Ischemic myocardial events",
            "percent": null
        },
        {
            "name": "Congestive heart failure",
            "percent": null
        },
        {
            "name": "Pulse absent",
            "percent": null
        },
        {
            "name": "Cyanosis",
            "percent": null
        },
        {
            "name": "Syncope",
            "percent": null
        },
        {
            "name": "Fatal",
            "percent": null
        },
        {
            "name": "life",
            "percent": null
        },
        {
            "name": "threatening",
            "percent": null
        },
        {
            "name": "and serious anaphylactic",
            "percent": null
        },
        {
            "name": "type reactions",
            "percent": null
        },
        {
            "name": "Cardiac",
            "percent": null
        },
        {
            "name": "cardiorespiratory arrest",
            "percent": null
        },
        {
            "name": "Clinically significant hypotension",
            "percent": null
        },
        {
            "name": "Syncope",
            "percent": null
        },
        {
            "name": "Unresponsiveness",
            "percent": null
        },
        {
            "name": "Loss of consciousness",
            "percent": null
        },
        {
            "name": "Tachycardia",
            "percent": null
        },
        {
            "name": "rhythm abnormalities",
            "percent": null
        },
        {
            "name": "Angioedema",
            "percent": null
        },
        {
            "name": "Ischemic myocardial events",
            "percent": null
        },
        {
            "name": "Acute myocardial ischemia with or without myocardial infarction or with in",
            "percent": null
        },
        {
            "name": "stent thrombosis in the context of hypersensitivity reactions",
            "percent": null
        },
        {
            "name": "Congestive heart failure",
            "percent": null
        },
        {
            "name": "Absent pulse",
            "percent": null
        },
        {
            "name": "Cyanosis",
            "percent": null
        }
    ]
}